» Articles » PMID: 11217817

Prevention in Liver Disease

Overview
Journal Am J Med Sci
Publisher Elsevier
Specialty General Medicine
Date 2001 Feb 24
PMID 11217817
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.

Citing Articles

Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.

Wu T, Huang S, Zhu F, Zhang X, Ai X, Yan Q Hum Vaccin Immunother. 2013; 9(11):2474-9.

PMID: 23887167 PMC: 3981858. DOI: 10.4161/hv.25814.


Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.

Lu L, Zeng M, Mao Y, Li J, Wan M, Li C World J Gastroenterol. 2003; 9(11):2480-3.

PMID: 14606080 PMC: 4656524. DOI: 10.3748/wjg.v9.i11.2480.